key: cord-0845078-oc3qaeiy
authors: Sun, Lei; Li, Pan; Ju, Xiaohui; Rao, Jian; Huang, Wenze; Zhang, Shaojun; Xiong, Tuanlin; Xu, Kui; Zhou, Xiaolin; Ren, Lili; Ding, Qiang; Wang, Jianwei; Zhang, Qiangfeng Cliff
title: In vivo structural characterization of the whole SARS-CoV-2 RNA genome identifies host cell target proteins vulnerable to re-purposed drugs
date: 2020-07-08
journal: bioRxiv
DOI: 10.1101/2020.07.07.192732
sha: 20322636a45c9b0a4e424c1bb216637522dba2d9
doc_id: 845078
cord_uid: oc3qaeiy

SARS-CoV-2 is an RNA virus of the Coronaviridae family that is the causal pathogen of the ongoing Coronavirus Disease 2019 pandemic. There are currently no antiviral drugs or vaccines to treat COVID-19, and the failure to identify effective interventions can be blamed on our incomplete understanding of the nature of this virus and its host cell infection process. Here, we experimentally determined structural maps of the SARS-CoV-2 RNA genome in infected human cells and also characterized in vitro refolded RNA structures for SARS-CoV-2 and 6 other coronaviruses. Our in vivo data confirms several structural elements predicted from theoretical analysis and goes much further in revealing many previously unknown structural features that functionally impact viral translation and discontinuous transcription in cells. Importantly, we harnessed our in vivo structure data alongside a deep-learning tool and accurately predicted several dozen functionally related host cell proteins that bind to the SARS-CoV-2 RNA genome, none of which were known previously. Thus, our in vivo structural study lays a foundation for coronavirus RNA biology and indicates promising directions for the rapid development of therapeutics to treat COVID-19. HIGHLIGHTS We mapped the in vivo structure and built secondary structural models of the SARS-CoV-2 RNA genome We discovered functionally impactful structural features in the RNA genomes of multiple coronaviruses We predicted and validated host cell proteins that bind to the SARS-CoV-2 RNA genome based on our in vivo RNA structural data using a deep-learning tool

Coronavirus Disease 2019 , caused by a coronavirus named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has spread globally and brought devastating to public health and economic damage, with more than 10 million people infected and 500 thousand deaths (Dong E et al., 2020; Wu et al., 2020) . Although huge global efforts have been devoted to understanding and fighting SARS-CoV-2-including extensive molecular virology studies examining the overall viral particle and viral protein structures (Gao et al., 2020; Lan et al., 2020; Walls et al., 2020; Yan et al., 2020) , transcriptome architectures (Kim et al., 2020) , and host cell-viral interactomes (Gordon et al., 2020) , as well as mechanistic studies of the virus infection process and antiviral immune responses (Hoffmann et al., 2020; Ni et al., 2020; Walls et al., 2020) -there are presently no effective antiviral treatments or approved vaccines.

SARS-CoV-2 is an RNA virus of the Coronaviridae family, which also includes the SARS-CoV virus that caused the SARS outbreak in 2003 (Peiris et al., 2003) and the Middle East respiratory syndrome coronavirus (MERS-CoV) that caused the MERS outbreak in 2012 (Zaki et al., 2012) . The genome of SARS-CoV-2 is an approximately 30kb, single-stranded, positive-sense RNA including a 5' cap structure and a 3' poly(A) tail. After cell entry, the viral genome can be translated into proteins directly, or can serve as the template for replication and transcription. During translation, SARS-CoV-2 produce nonstructural proteins (nsps) from two open reading frames (ORF1a and ORF1b), and a number of structural proteins from subgenomic viral RNAs. Upon production of negative-sense RNA by the nsp12 protein (an RNA-dependent RNA polymerase), both positive-sense genomic RNA and sub-genomic RNAs can be generated. The RNA comprising the SARS-CoV-2 genome is packaged by structural proteins encoded by sub-genomic RNAs.

It is notable that a large majority of molecular virology studies of SARS-CoV-2 (and indeed studies of most other viruses) have focused on viral proteins. For example, structural determination of the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 bound to the cell receptor ACE2 provided atomic details on the initial step of infection (Lan et al., 2020; Walls et al., 2020; Yan et al., 2020) . Knowledge of SARS-CoV-2-human proteinprotein interactions revealed the basis of how SARS-CoV-2 reshapes cellular pathways and identified druggable host factors for FDA-approved drugs and small compounds (Gordon et al., 2020) . And tracking and analysis of changes in the key proteins of SARS-CoV-2 discovered an important mutation that is associated with increased transmission (Korber et al., 2020) . These studies have been valuable for revealing mechanistic insights to deepen understanding of molecular virology and epidemiology and to aid development of antiviral therapeutics.

However, SARS-CoV-2 is an RNA virus; its RNA genome itself is a central regulatory hub for controlling and enabling its function. Recent advances in technologies and basic studies have emphasized that RNA molecules in cells fold into complex, higher-order structures that are integral to their cellular functions (Brion and Westhof, 1997; Piao et al., 2017) . For viruses specifically, there are many examples of functional impacts from such RNA structural elements: studies of flaviviruses have confirmed that intramolecular RNA-RNA interactions between the 5'-and the 3'-UTRs promote genome circularization and help coordinate replication (de Borba et al., 2015; Nicholson and White, 2014) ; the structure of the internal ribosome entry site in 5'UTR is crucial for hepatitis C virus (HCV) translation (Fraser and Doudna, 2007; Kieft, 2008) ; and the multi-pseudoknot structures in the 3' UTR of ZIKV and other flaviviruses have been shown to stall the RNA exonuclease Xrn1, thereby giving rise to sub-genomic flavivirus RNAs (sfRNAs) that help the virus evade cellular antiviral processes (Akiyama et al., 2016; Filomatori et al., 2017) . However, despite functional characterization of several RNA structural elements of SARS (Robertson et al., 2005) , and theoretical predictions recently available along with the sequences of SARS-CoV-2 (Andrews et al., 2020; Rangan et al., 2020) , it is clear that a more comprehensive analysis of the structure of the SARS-CoV-2 RNA genome as it exists in a physiologically-relevant state in cells would be highly desirable.

Previous studies in other RNA viruses have identified numerous host RNA binding proteins (RBPs) that function to regulate the viral infection cycle (Li and Nagy, 2011; Ooi et al., 2019) , but we are unaware of such information for SARS-CoV-2. Our group recently demonstrated that RNA structural data can be assessed using cutting-edge deep learning techniques to construct neural network models that integrate in vivo RBP binding and RNA features in matched cells, yielding accurate predictions about in vivo RBP-virus genome binding interactions . Given the centrality of such interactions to understanding how viruses engage with their host cells, a large-scale survey and/or prediction to determine which host RBPs interact with SARS-CoV-2 genomic RNAs during infection would be an extremely rich resource for molecular insights.

In the present study, we first investigated the in vivo and in vitro RNA secondary structures of SARS-CoV-2, as well as the structures of the untranslated regions (UTRs) structures of six related coronaviruses using a high-throughput technology known as in vivo click selective 2hydroxyl acylation and profiling experiment (icSHAPE) (Spitale et al., 2015) . We experimentally determined structural maps of the SARS-CoV-2 genome in infected human cells, and also characterized the in vitro refolded RNA structures of SARS-CoV-2 and 6 other coronaviruses. Based on the in vivo structural data, we then used our deep learning tool to accurately predict several dozen functionally related host cell proteins that bind to the SARS-CoV-2 RNA genome ; among these host proteins many are vulnerable drug target.

To delineate the genome-wide structure of SARS-CoV-2 in infected cells, we performed in vivo click selective 2-hydroxyl acylation and profiling experiments (icSHAPE) to assess structural information for every nucleotide of the RNA genome ( Figure 1 . STAR Methods). Specifically, after infecting Huh7 cells with SARS-CoV-2 for 30 hours, we treated cells with the icSHAPE reagent NAI-N3, which permeates cells, selectively reacts with single stranded nucleotides, and introduces a modification to the 2'-OH group of the sugar ring. We then purified the total RNA and performed reverse transcription, followed by cDNA sequencing library construction. Note that NAI-N3-modifications which tag single-stranded nucleotides functionally block reverse transcriptase, thus enabling detection of single-stranded nucleotides based on deep sequencing and bioinformatics analysis. Finally, we obtain an icSHAPE reactivity score for each nucleotide of the viral RNA genome (and the host cell transcriptome); scores are between 0 and 1, with higher scores indicating that a nucleotide is more likely single-stranded. Thus, based on mapping of the single-stranded nucleotides, icSHAPE analysis enables elucidation of the structural landscape of all RNAs in vivo.

For the in vivo icSHAPE structural map of the SARS-CoV-2 RNA genome, we obtained an average of about 200 million reads for each library replicate (Supplementary Table S1 ).

Underscoring the very high quality of our sequencing data, we found that the inter-replicate Pearson correlation coefficient values are higher than 0.98 for comparison of RNA expression (RPKM) levels of the host transcriptome ( Figure S2A -C); and the correlation of the RT-stopcausing NAI-N3 modifications on the viral RNA genome exceeds 0.99 ( Figure S2D ). Finally, we obtained icSHAPE scores for more than 99.88% of the nucleotides for in vivo SARS-CoV-2 RNA genome structure, by using icSHAPE-pipe (Figure 2, Supplementary   Table S2) .

We initially assessed the accuracy of our in vivo structure based on comparisons with the very recently published theoretical models of the 5'UTR and 3'UTR secondary RNA structures built from homology based on literature-annotated structures in related betacoronaviruses (Rangan et al., 2020) , as well as in the Rfam database based on co-variation and pairing energy values (Kalvari et al., 2018) . We built the 5'UTR and 3'UTR structure models with RNA structure modeling software tools (here we used RNAstructure) (Reuter and Mathews, 2010) , using icSHAPE scores as constraints ( Figure 2E ); such methods have been extensively used and validated by other groups and ours in RNA structural studies including viral RNA structures (Li et al., 2018; Pirakitikulr et al., 2016; Watts et al., 2009) 

Attesting to the quality of the map generated from our in vivo data, the single-base resolution SARS-CoV-2 models are in strong agreement with reported structural information from predictive and in vitro studies (compare Figure 2E and Figure S2A -B). That is, we can easily identify the anticipated Stem-loop 1 (SL1), Stem-loop 2 (SL2), Stem-loop 3 (SL3), Stem-loop 4 (SL4), and the hyper-variable region (HVR) comprising a conserved octonucleotide sequence and the stem-loop II-like motif (s2m) in the 3'UTR ( Figure 2E ).

Small differences exist between our model and the Das theoretical model (shown in red dashed-line boxes, Figure 2E and Figure S2A -B), including for example the absence of a small stem-loop downstream of SL4 in the 5'UTR of our model. Our structural reactivity data based on data from Huh7 cells suggest that this region is highly single-stranded. Another difference is that we detected a stem loop structure rather than a pseudoknot in the 3'UTR of the SARS-CoV-2 genome; this alternative structural interpretation is supported by the high icSHAPE score constraint that would occur in a pseudoknot configuration. These findings highlight that in vivo structural information is critical for building of physiologically relevant structural models.

We also used icSHAPE to conduct in vitro structural analysis of the SARS-CoV-2 RNA genome. SARS-CoV-2 RNA was purified from infected Huh7 cells, refolded in vitro, then modified with NAI-N3, with the remaining steps and data analysis the same as in vivo icSHAPE ( Figure 1B , Figure 2C ). Similar to previous studies (Spitale et al., 2015; Sun et al., 2019) , comparative analysis between in vitro and in vivo data focused on the revealed many common stable structural regions, but also indicated substantial differences, with a 0.58 Pearson correlation coefficient between the in vitro and in vivo structural profiles at the whole-genome level ( Figure 2D , Figure S1E ). Additionally, and consistent with findings from previous studies of viral RNA genome structure, comparisons of our models indicated that the SARS-CoV-2 RNA genome in vivo appears to be more single-stranded than in vitro ( Figure S1F ). These detected differences between our in vitro and in vivo structural profiles strongly emphasize the utility of studying RNA structures in their cellular context to uncover biologically relevant conformations.

We extended the validated approach of in vivo RNA structure modeling with icSHAPE scores as constraints to the whole SARS-CoV-2 RNA genome (STAR Methods). We tested different parameters for modeling of the SARS-CoV-2 5'UTR and 3'UTR structures, and then used the parameters which generated the most consistent structure with the Das and Rfam models to conduct genome-wide modeling. Given that RNA structural modeling is typically most successful with small RNA fragments (Li et al., 2018) , we used a sliding window (window = 5000nt, step = 1000nt) strategy to more accurately model RNA structures; note that we followed a common strategy of preferencing structure models with higher pairing probabilities when modeling RNA structures of overlapping regions.

We assessed co-evolutionary evidence to support our final models based on the R-scape tool and on a previously reported pipeline to call co-variant pairs from 258 coronavirus genomes ( Figure S2C . STAR Methods) (Li et al., 2018; Pirakitikulr et al., 2016) . In total, we found 143 co-variant pairs, including 6 in the 5'UTR, and 12 in the 3'UTR (Figure 3 , S3). The flanking regions of the UTR also contains many co-variant pairs (1 in 5'UTR flanking and 19 in 3'UTR flanking), indicating potential regulatory impacts from these detected RNA structures.

Interestingly, we observed a strong combination of 5 co-variations within a duplex formed by the interaction between 3'UTR and "ORF10", a flanking cryptic ORF. ORF10 was predicted computationally, but has not been supported with any protein-level evidence (Kim et al., 2020) , and a recent study using nanopore direct RNA sequencing did not identify the predicted subgenomic RNA ORF10. Our structural data raised the possibility that this region may be a part of the 3'UTR, potentially functioning as a stable RNA structure ( Betacoronavirus). Note that the 5'UTR sequences all included about 300 nt of flanking sequence. We synthesized the corresponding DNA sequences and used in vitro transcription to obtain the RNA fragments. Following re-folding, we applied NAI-N3 and then characterized their RNA structures using icSHAPE.

Of particular note, a recent study found that a SARS-CoV-2 variant with a glycine at the residue 614 of the Spike protein may confer a fitness advantage; this variant has become the dominant pandemic form of the virus (Korber et al., 2020) . The study's authors suggested that this mutation may facilitate cell entry or reduce immune response to increase overall transmission rates. Interestingly, this mutation is almost invariably accompanied by a 241 Cto-T mutation in the SARS-CoV-2 5'UTR. We therefore included the SARS-CoV-2-241T mutant in our comparative structural analyses, and we did observe a modest structural change around this position ( Figure 4B ), suggesting that this non-coding mutation may also contribute to an increase in transmission.

Over all the sequences we examined, icSHAPE profile data for these diverse noncoding genome regions revealed conserved structures characteristic of the various genera and linages, largely consistent with the phylogeny ( Figure 4B ), both in 5'UTR ( Figure S4 ) and 3'UTR ( Figure S5 ). For example, the 5'UTRs for all of the lineage B group members (SARS-CoV and SARS-CoV-2) each contain 7 stem-loop RNA structures, and these structures occur in the same order ( Figure 4C , S4A). Remarkably, lineage C group (MERS-CoV and BtCoV-HKU5) also contain seven almost identical stem-loops, again in the same order, even though these viruses have a sequence similarity of only 46.5%~47.3% with lineage B ( Figure S4B ). The more distant lineage D betacoronavirus (BtCoV-HKU9) also contains seven similar stem-loops, despite having only 39.3~40.7% sequence similarity with lineage B and C ( Figure S4B ). Nevertheless, lineage D virus has slightly longer SL6 and SL7 than lineage B and C ( Figure 4C, S4A) .

Notably, although some theoretical models based on co-variation show similar structural architecture ( Figure S4C ), others are very different and miss conserved structural elements ( Figure S4D , MERS-CoV, BtCoV-HKU9).

Strikingly, despite having similar levels of sequence similarity to betacoronaviruses of lineages B, C, and D, the lineage A betacoronavirus (HCoV-HKU1) and Alphacoronavirus (HCoV-NL63) (37.5%~ 46.3% in 5'UTR and 35.0%~45.2% in 3'UTR) each form very different structures, although all share stem-loop SL1( Figure S4B , S4E and S5B). This structural divergence suggests that the non-coding regions of these viruses may exert distinct functions and may be subject to different forms of regulation. Our characterization of structural features from 7 coronavirus lineages in combination with our phylogenetic analysis revealed how coronavirus evolution has resulted conserved as well as divergent RNA structures.

In vivo RNA structure predicts translation efficiency and species abundance of subgenomic RNA RNA structure affects the localization, splicing, translation efficiency (TE), and stability of cellular RNA on a genome-wide scale (Bevilacqua et al., 2016; Mortimer et al., 2014; Piao et al., 2017; Wan et al., 2011) . Previous studies have reported positive correlations between translation efficiency and the frequency of single-stranded regions in the 5'-UTR of a given RNA transcript (Beaudoin et al., 2018; Mustoe et al., 2018) . SARS-CoV-2 generates a number of subgenomic viral RNA sequences which encode important structural proteins including the spike protein, the envelop protein, the membrane protein, the nucleocapsid protein, and other accessory proteins ( Figure S6A ) (Kim et al., 2020) . By correlating our in vivo SARS-CoV-2 RNA structure data with translation efficiency (TE) data of subgenomic viral RNAs reported in a recent study (Bojkova et al., 2020) , we found a high Pearson correlation coefficient between TE and RNA structural features (r = 0.717, p =0.029, Figure S6B ). That is, for SARS-CoV-2 RNAs in cells, the TE is generally higher for RNA molecules of more single-stranded 5'-UTR5'-UTR.

We also found that the abundance of a given subgenomic viral RNA is positively correlated with the frequency of single-stranded regions present in its structure. For context, subgenomic viral RNAs are generated from the minus-strand of viral RNA intermediates that are synthesized via a process known as "discontinuous transcription". In this process, A recent study reported quantification of the SARS-CoV-2 subgenomic viral RNA population based on long-read sequencing (Kim et al., 2020) . Using this abundance data alongside our structural data, we detected a positive correlation between the abundance of a particular subgenomic viral RNA and the level of single-stranded regions positioned within its 5' TRS-B region ( Figure 5A , left, r = 0.24, p = 0.035). Pursuing this, we re-examined our sequencing data from the initial icSHAPE analysis to accurately calculate RNA structure scores for the TRS-L region of each subgenomic viral RNA, specifically by identifying and exclusively counting those reads that i) cross a fusion site and ii) specifically map to a confirmed subgenomic viral RNA ( Figure S6A , left, STAR method). Again, subgenomic viral RNAs if more single-stranded TRS-L were much more abundant ( Figure 5A , right, r = 0.43, p = 0.004. See an example of N and pp1ab in Figure 5B ), supporting that the overall abundance of a particular viral RNA molecule is strongly impacted by its RNA 5' structure, presumably because of differential impacts on discontinuous transcription.

The coupling of transcription and translation of cellular RNAs is an important phenomenon in gene expression, fulfilled through different mechanism of regulation, including m6A, RNA polymerase II subunits and promoter sequences (Harel-Sharvit et al., 2010; Slobodin et al., 2017; Zid and O'Shea, 2014) . In our previous study, we established RNA structure as a link in connecting transcription and translation. In our present analysis of SARS-CoV-2 subgenomic RNAs, we also observed apparent impacts of RNA structure on the coordination of subgenomic viral RNA generation and translation ( Figure 5C ). Collectively, our in vivo RNA structure predicts and connects the abundance and the translation efficiency of SARS-CoV-2 subgenomic RNAs.

Host cell RNA binding proteins (RBPs) play essential roles in regulating virus translation, replication, and degradation (Li and Nagy, 2011; Ooi et al., 2019) . Thus, characterizing interactions between RBPs and viral RNA is a is fundamental step for understanding the infection process and for identifying potential targets to enable development of innovative antivirus therapies. Although genome-scale viral RNA genome data is relatively scarce and methods to predict and detect viral RNA genome-host RBP interactions are only in their infancy, it is notable that previous studies have reported functional interactions between RBPs and the 5'UTRs of coronavirus genomes (Sola et al., 2011b) . Our group has recently developed a tool-PrismNet (Protein-RNA Interaction by Structure-informed Modeling using deep neural Network)-which we here employed to predict host RBPs and their putative RNA genome binding sites . Very briefly, PrismNet constructs and trains a deep neural network to model the interactions between an RBP and its RNA target by integrating big data from in vivo RBP binding assays and RNA structural analyses obtained from matched cellular conditions.

We applied PrismNet to predict RBP binding on the SARS-CoV-2 RNA genome, and identified 40 and 43 host proteins that bind to the 5'UTR and 3'UTR, respectively ( Figure 6A , Supplementary Table S5 ). Several of our predicted proteins were previously reported to directly or potentially binding with RNA of other coronaviruses. For example, the heterogeneous nuclear ribonucleoprotein hnRNPA1 was shown to bind with viral RNA and impact RNA synthesis for mouse hepatitis virus (MHV) (Shi et al., 2000) . PTBP1 was reported to bind to transmissible gastroenteritis virus (TGEV) RNA and is involved in viral gene expression (Sola et al., 2011a) . The NPM1 protein interacts with the nucleocapsid protein of SARS-CoV, which affects viral particle assembly (Zeng et al., 2008) . Although there are no studies reporting any association of the autoimmune-disease-related protein TROVE2 (Reed and Gordon, 2016) with coronavirus infection; however, we found that TROVE2 shows high affinity (0.979) with SARS-CoV-2 RNA based on our prediction, identifying it as a candidate host RBP to help study how SARS-CoV-2 infection may deleteriously impact host immune responses.

Inhibition of stress granules affects the replication of MERS-CoV, and our analysis predicted that several stress-granule-related proteins such as TIA1 (Onomoto et al., 2014) , IGF2BP1, and ELAVL1 (Markmiller et al., 2018) also showed high affinity with SARS-CoV-2 RNA. These multiple predictions collectively indicate that SARS-CoV-2 infection may somehow inhibit formation of stress granules in host cells, perhaps in a manner similar to MERS-CoV's hijacking of related RBPs. We therefore focused on IGF2BP1, TIA1, and PTBP1 as a potential host factors for SARS-CoV-2 infection to validate our prediction data. We synthesized 2 host sequences which include the SL2, SL3 fragment (Target 1) and the SL4 fragment (Target 2) to use in RNA pull-down assays ( Figure 6A ). PrsimNet predicted IGF2BP1, TIA1, and PTBP1 bound to SARS-CoV-2 RNA (with binding probabilities: 0.947, 0.805 and 0.841). Our pull-down assays showed that the detected binding strengths correlated well with the predicted binding scores based on the saliency map from PrismNet ( Figure 6B -D, left).

Specifically, TIA1 only bound to Target1, whereas PTBP1 also exhibited very weak affinity for Target2. IGF2BP1 can bind to both of the Target1 and Target2, albeit with stronger affinity for Target 2 ( Figure 6B -D, right). Our empirical data thus support that PrimNet can accurately predict host proteins that bind to the SARA-CoV-2 RNA genome, opening the door for multiple hypothesis-driven studies to determine whether and how such binding interactions with these host RBPs may regulate viral infectivity.

In this study we experimentally determined structural maps of the SARS-CoV-2 genome in infected human cells, as well as the structure for in vitro refolded RNA of SARS-CoV-2 and 6 other coronaviruses. Our host cell data confirms the presence of stable, conserved structural elements from theoretical analysis, while also revealing many previously unknown structural features that apparently affect viral translation and discontinuous transcription in cells. Based on our in vivo structure data, we then accurately predicted several dozen functionally related host cell proteins that bind to the SARS-CoV-2 RNA genome by using a deep learning neural network, and finally showed that some of these host proteins are vulnerable drug targets for reducing SARS-CoV-2 infection.

In addition to encoding viral proteins, the SARS-CoV-2 RNA genome itself functions as a molecular hub to interact with many cellular factors, presenting multiple levels of complexity for the regulation of viral infection and disease. As discovered previously for many other viruses, including HIV (Watts et al., 2009) , HCV (Pirakitikulr et al., 2016) , dengue (Dethoff et al., 2018) , and ZIKV (Li et al., 2018) , much of the regulation and function of RNA viral genomes is mediated by higher-order RNA structures. For coronaviruses, studies have also identified different RNA structure elements that functionally impact viral life cycles. Most coronavirus 5' UTR's harbor a number of loops, with many showing heightened sequence conservation across betacoronaviruses, and various stems demonstrating functional roles in viral replication. For example, studies suggested that the first stem-loop (SL1) the in 5'UTR is necessary for viral replication (Li et al., 2008) . Flanking the 5'UTR of SARS-CoV-2, the third stem-loop contains a TRS core sequence (CS region, CUAAAC), and PrismNet predicted that some RBPs bind with this genome structure (Figure 6 ), suggesting that it is critical for discontinuous transcription characteristic to coronaviruses. In viral genome 3'UTRs, mutually exclusive RNA structures have been shown to control various stages of the RNA synthesis pathway. Recent virus structural modeling efforts using SARS-CoV-2 genome sequences have confirmed the existence of many of these stem-loops and driven predictions of yet more of these in SARS-CoV-2 (Andrews et al., 2020; Rangan et al., 2020) .

Our work emphasized that most stem-loops exist in both re-folded RNA molecules and in viruses within host cells, implying that these robustly auto-generating structures are very likely to exert functional impacts. Interestingly, we observed that the proposed loop region in SL3 is not reactive, supporting the possibility of long-range functional interactions with downstream TRS-B regions, which is understood as integral for successfully discontinuous transcription (Enjuanes et al., 2006) . We also noticed that the small stem-loop downstream of SL4 proposed by the Das model is absent from our in vivo structural data; rather than a stem-loop, our results indicate this regions adopts a long, single-stranded conformation in vivo; interestingly, the sequence context of this region is AU-rich, suggesting it may be a hotspot for the binding of RBPs that prefer AU-rich single-stranded structure elements.

Guided by recent epidemiological reports, we analyzed the C-to-T mutation at the 241 nt, which is positioned in the loop region of SL5. This mutation both creates a poly-U sequence motif and modestly increases its preference to adopt a single-stranded conformation, thereby potentially creating an attractive binding site for RBPs that bind to single-stranded poly-U sequences. Our findings thus offer structural insights to help better understand how this nowprevalent SARS-CoV-2-241T allele is contributing to increased rates of transmission.

Beyond confirming the presence of a long, single-stranded region between SL3 and SL4, our study identified many more such regions in the SARS-CoV-2 genome. These regions should be understood as potentially attractive target sequences for interventions using technologies like siRNA, ASO, and sgRNA. Importantly, our work also revealed structural elements having strong co-evolution support, which usually suggests stable, functionally conserved RNA structures, throughout the genome (including in CDS regions). Computational methods like ROSETTA and FARFAR have become efficient for tertiary structure modeling when accurate secondary structural models are available. It is thus possible to build reliable tertiary structure models for some parts of the SARS-CoV-2 genome; such efforts may reveal druggable pockets vulnerable to small molecules. Indeed, there are previously reported examples for specifically targeting such functional RNA structural elements to disrupt viral infectivity (Ren and Patel, 2014) , so the elucidation of RNA structures can facilitate target discovery and the development of antiviral therapeutics.

Our in vivo RNA structure provides a groundwork to accurately predict host RBPs that bind to SARS-CoV-2 genome, as we have demonstrated recently in different cellular contexts.

We used a deep learning method, PrismNet, trained on more than 1594 binding sites together with in vivo RNA structures obtained from matched cell lines for 99 RBPs. Our application of PrismNet here strongly supports the accuracy of its predicted interactions. In addition to recruiting the necessary translation machineries, SARS-CoV-2 potentially interacts with many RNA metabolism proteins including helicases based on our prediction ( such as DDX42), which potentially are hijacked by the virus to help evade cell innate immune response (Beachboard and Horner, 2016) . In particular, the results also revealed a few stress granule proteins interacting with SARS-CoV-2 genome (Such as TIA1). Previous study has identified West Nile virus minus-strand 3' terminal stem loop (SL) RNA specifically interact with stress granule compartments TIA1 and facilitates flavivirus genome RNA synthesis, also inhibits SG formation (Emara and Brinton, 2007) . The information of how SARS-CoV-2 RNA genome interact with host cellular proteins has been extremely limited by now. Our results thus provide a rich resource to understanding the molecular mechanism of viral infection.

The identification of host RBPs that bind to RNA genomes can be exploited as a unique opportunity for the effective development of antiviral drugs. For example, drugs targeting DDX42 may inhibit the function of DDX42 that SARS-CoV-2 are more sensitive to innate immune system. Certainly, many more studies will be required before any of the drugs identified by our study can be deployed as therapeutics for treating But overall, the data in our study clearly has great promise for the repurposing of existing drugs and the identification of new agents that target the in vivo viral RNA structure and host RBPs to fight against the still-ongoing pandemic and to combat viral disease more generally. Nucleotides are colored with icSHAPE reactivity scores, blue bars show base-pairs with high pairing probability, and nucleotides with color backgrounds were predicted as covariation base-pairs. The two-tailed P value was calculated using the Python package function scipy.stats.pearsonr. r is the Pearson correlation efficient. (B) The icSHAPE profile and structural models of the TRS-L region of the subgenomic RNAs of nucleocapsid (N) and polypeptide 1b (pp1b), predicting the relative abundance of the subgenomic RNAs. RNA structural models were here predicted using the icSHAPE score constraint, as above (see Fig 2E) . Stop codon BtCoV-HKU9 AUC=0.848 Target1 Target2   Target1  Target2   IGF2BP1   GAPDH   TIA1   GAPDH   GAPDH   PTBP1   Target1  Target2  Control   Target1  Target2  Control   Target1 Target2 Control 

A U U A A A G G U U U A U A C C U U C C C A G G U A A C A A A C C A A C C A A C U U U C G A U C U C U U G U A G A U C U G U U C U C U A A A C G A A C U U U A A A A U C U G U G U G G C U G U C A C U C G G C U G C A U G C U U A G U G C A C U C A C G C A G U A U A A U U A A U A A C U A A U U A C U G U C G U U G A C A G G A C A C G A G U A A C U C G U C U A U C U U C U G C A G G C U G C U U A C G G U U U C G U C C G U G UU G C A G C C G AUCA U C A G C A C A U C U A G G U U U C G U C C G G G U G U G A C C G A A A G G U A A G A U G G A G A G C C U U G U C C C U G G U U U C A A C G A G A AU C A U G C A G A C C A C A C A A G G C A G A U G G G C U A U A U A A A C G U U U U C G C U U U U C C G U U U A C G A U A U A U A G U C U A C U C U U G U G C A G A A U G A A U G A C 29560 29580 29600 29620 29621 U U C U C G U A A C U A C A U A G C A C A A G U A G A U G U A G U U A A C U U U A A U C U C A C A U A U C C C C A U G U G A U U U U A A U A G C U U C U U A G G A G A A 29640 29660 A G C G C U 29840 29860 Stop codon ORF10 Start codon A A U C U U U A A U C A G U G U G U A A C A U U A G G G A G G A C U U G A A A G A G C C A C C A C A U U U U C A C C G A G G C C A C G C G G A G U A C G A U C G A G U G U A C A G U G A A C A A U G C U A G G G A G A G C U G C C U A U A U G G A A G A G C C C U A A U G U G U A A A A U U A A U U U U A G U A G UU G G U G C A G A A A A U U C A G U U G C U U A C U C U A A U A A C U C U A U U G C C A U A C C C A C A A A U U U U A C U A U U A G U G U U A C C A C A G A A A U U C U A C C A G U G U C U A U G A C C A A G A C A U C A G U A G A U U G U A C A A U G U A C A U U U G U G G U G A U U C A A C U G A A U G C A G C A A U C U U U U G U U G C A A U A U G G C A G U U U U U G U A C A C A A U U A A A C C G U G C U U U A A C U G G A A U A G C U G U U G A A C A A G A C A A A A A C A C C C A A G A A G U U U U U G C A C A A G U C A A A C A U U 23700 23800 23900 U C A C A A A U A U U A C C A G A U C C A U C A A A A C C A A G C A A G A G G U C A U U U A U U G A A G A U C U A C U U U U C A A C A A A G U G A C A C U U G C A G A U G C U G G C U U C A U C A A A C A A U A U G G U G A U U G C C U U G G U G A U A U U G C 24000 A U U A A A G G U U U A U A C C U U C C C A G G U A A C A A A C C A A C C A A C U U U C G A U C U C U U G U A G A U C U G U U C U C U A A A C G A A C U U U A A A A U C U G U G U G G C U G U C A C U C G G C U G C A U G C U U A G U G C A C U C A C G C A G U A U A A U U A A U A A C U A A U U A C U G U C G U U G A C A G G A C A C G A G U A A C U C G U C U A U C U U C U G C A G G C U G C U U A C G G U U U C G U C C G U G U U G C A G C C G A U C A U C A G C A C A U C U A G G U U U C G U C C G G G U G U G A C C G A A A G G U A A G A U G G A G A G C C U U G U C C C U G G U U U C A A C G A G A A A A C A C A C G U C C A A C U C A G U U U G C C U G U U U U A C A G G U U C G C G A C G U G C U C G U A C G U G G C U U U G G A G A C U C C G U G G A G G A G G U C U U A U C A G A G G C A C G U 100 200 305 Start codon ORF1ab U A U C U C U U C U U A G U A A A G G U A G A C U U A U A A U U A G A G A A A A C A A C A G A G U U G U U A U U U C U A G U G A U G U U C U U G U U A A C A A C U A A A C G A A C A A U G U U U G U U U U U C U U G U U U U A U U G C C A C U A G U C U C U A G U C A G U G U G U U A A U C U U A C A A C C A G A A C U C A A U U A C C C C C U G C A U A C A C U A A U U C U U U C A C A C G U G G U G U U U A U U A C C C U G A C A A A G U U U U C A G A U C C U C A G U U U U A C A U U C A A C U C A G G A C U U G U U C U U A C C U U U C U U U U C C A A U G U U A C U U G G U U C C A U G C U A U A C A U G U C U C U G G G A C C A A U G G U A C U A A G A G G 21500 21600 21700 U U U G A U A A U 21800 C C C U G U C C U A C C A U U U A A U G A U G G U G U U U A U U U U G C U U C C A C U G A G A A G U C U A A C A U A A U A A G A G G C U G G A U U U U U G G U A C U A C U U U A G A U U C G A A G A C C C A G U C C C U A C U U A U U G U U A A U A A C G C U A C U A A U G U U G U U A U U A A A G U C U G U G A A U U U C A A U U U U G U A A U G A U C C A U U U U U G G G U G U U U A U U A C C A C A A A A A C A A C A A A A G U U G G A U G G A A A G U G A G U U C A G A G U U U A U U C U A G U G C G A A U A A U U G C A C U U U U G A A U A U G U C U C U C A G C C U U U U C U U A U G G A C C U U G A A G G A A A A C A G G G 21900 22000 22100 U C A A A A A U C U U A G G G A A U U U G U G U U U A A G A A U A U U G A U G G U U A U U U U A A A A U A U A U U C U A A G C A C A C G C C U A U U A A U U U A G U G C G U G A U C U C C C U C A G G G U U U U U C G G C U U U A G A A C C A U U G G U A G A U U U G C C A A U A G G U A U U A A C A U C A C U A G G U U U C A A A C U U U A C U U G C U U U A C A U A G A A G U U A U U U G A C U C C U G G U G A U U C U U C U U C A G G U U G G A C A U G C A G C U U A U U A U G U G G G U U A U C U U C A A C C U A G G A C U U U U C U A U U A A A A U A U A A U G A A A A U G G A A C C A U U A C A G A U G C U G U A G A C U G U G G A C C C U C U C U C A G A A A C A C A C U U A A G U G U A C G U U G A A A U C C U U C A C U G U A G A A A A A G G A A U C U A U C A A A C U U C U A A C U U U A G A G U C C A A C C A A C A G A A U C U A U U G U U A G A U U U C C U A A U A U U A C A A A C U U G U G C C C U U U U G G U G A A G U U U U U A A C G C C A C C A G A U U U G C A U C U G U U U A U G C U U G G A A C A G G A A G A G A A U C A G C A A C U G U G U U G C U G A U U A U U C U G U C C U 22200 22300 22400 22500 22600 A A U U G C U G G U G C A U A U A A U U C C G C A U C A U U U U C C A C U U U U A A G U G U U A U G G A G U G U C U C C U A C U A A A U U A A A U G A U C U C U G C U U U A C U A A U G U C U A U G C A G A U U C A U U U G U A A U U A G A G G U G A U G A A G U C A G A C A A A U C G C U C C A G G G C A A A C U G G A A A G A U U G C U G A U U A U A A U U A U A A A U U A C C A G A U G A U U U U A C A G G C U G C G U U A U A G C U U G G A A U U C U A A C A A U C U U G A U U C U A A G G U U G G U G G U A A U U A U A A U U A C C U G U A U A G A U U G U U U A G G A A G U C U A A U C U C A A A C C U U U U G A G A G A G A U A U U U C A A C U G A A A U C U A U C A G G C C G G 22700 22800 22900 U A G C A C A C C U U G U A A U G G U G U U G A A G G U U U U A A U U G U U A C U U U C C U U U A C A A U C A U A U G G U U U C C A A C C C A C U A A U G G U G U U G G U U A C C A A C C A U A C A G A G U A G U A G U A C U U U C U U U U G A A C U U C U A C A U G C A C C A G C A A C U G U U U G U G G A C C U A A A A A G U C U A C U A A U U U G G U U A A A A A C A A A U G U G U C A A U U U C A A C U U C A A U G G U U U A A C A G G C A C A G G U G U U C U 23000 23100 23200 U A C U G A G U C U A A C A A A A A G U U U C U G C C U U U C C A A C A A U U U G G C A G A G A C A U U G C U G A C A C U A C U G A U G C U G U C C G U G A U C C A C A G A C A C U U G A G A U U C U U G A C A U U A C A C C A U G U U C U U U U G G U G G U G U C A G U G U U A U A A C A C C A G G A A C A A A U A C U U C U A A C C A G G U U G C U G U U C U U U A U C A G G A U G U U A A C U G C A C A G A A G U C C C U G U U G C U A U U C A U G C A G A U C A A C U U A C U C C U A C U U G G C G U G U U U A U U C U A C A G G U U C U A A U G U U U U U C A A A C A C G U G C A G G C U G U U U A A U A G G G G C U G A A C A U G U C A A C A A C U C A U A U G A G U G U G A C A U A C C C A U U G G U G C A G G U A U A U G C G C U A G U U A U C A G A C U C A G A C U A A U U C U C C U C G G C G G G C A C G U A G U G U A G C U A G U C A A U C C A U C A U U G C C U A C A C U A U G U 23300 23400 23500 23600 A A U U U A C A A A A C A C C A C C A A U U A A A G A U U U U G G U G G U U U U A A U U G C U A G A G A C C U C A U U U G U G C A C A A A A G U U U A A C G G C C U U A C U G U U U U G C C A C C U U U G C U C A C A G A U G A A A U G A U U G C U C A A U A C A C U U C U G C A C U G G U G C A G G U G C U G C A U U A C A A A U A C C A U U U G C U A U G C A A A U G G C U U A U A G G U U U A A U G G U 24100 G U U A G C G G G U A C A A U C A C U U C U G G U U G G A C C U U U 24200 U A U U G G A G U U A C A C A G A A U G U U C U C U A U G A G A A C C A A A A A U U G A U U G C C A A C C A A U U U A A U A G U G C U A U U G G C A A A A U U C A A G A C U C A C U U U C U U C C A C A G C A A G U G C A C U U G G A A A A C U U C A A G A U G U G G U C A A C C A A A A U G C A C A A G C U U U A A A C A C G C U U G U U A A A C A A C U U A G C U C C A A U U U U G G U G C A A U U U C A A G U G U U U U A A A U G A U A U C C U U U C A C G U C U U G A C A A A G U U G A G G C U G A A G U G C A A A U U G A U A G G U U G A U C A C A G G C A G A C U U C A A A G U U U G C A G A C A U A U G U G A C U C A A C A A U U A A U U A G A G C U G C A G A A A U C A G A G C U U C U G C U A A U C U U G C U G C U A C U A A A A U G U C A G A G U G U G U A C U U G G A C A A U C A A A A A G A G U U G A U U U U U G U G G A A A G G G C U A U C A U C U U A U G U C C U U C C C U C A G U C A G C A C C U C A U G G U G U A G U C U U C U U G C A U G U G A C U U A U G U C C C U G C A C A A G A A 24300 24400 24500 24600 24700 A A G A A C U U C A C A A C U G C U C C U G C C A U U U G U C A U G A U G G A A A A G C A C A C U U U C C U C G U G A A G G U G U C U U U G U U U C A A A U G G C A C A C A C U G G U U U G U A A C A C A A A G G A A U U U U U A U G A A C C A C A A A U C A U UA C U A C A G A C A A C A C A U U U G U G U C U G G U A A C U G U G A U G U U G U A A U A G G A A U U G U C A A C A A C A C A G U U U A U G A U C C U U U G C A A C C U G A A U U A G A C U C A U U C A A G G A G G A G U U A G A U A A A U A U U U U A A G A A U C A U A C A U C A C C A G A U G U U G A U U U A G G U G A C A U C U C U G G C A U U A A U G C U U C A G U U G U A A A C A U U C A A A A A G A A A U U G A C C G C C U C A A U G A G G U U G C C A A G A A U U U A A A U G A A U C U C U C A U C G A U C U C C A A G A A C U U G G A A A G U A U G A G C A G U A U A U A A A A U G G C C A U G G U A C A U U U G G C U A G G U U U U A U A G C U G G C U U G A U U G C C A U A G U A A U G G U G A C A A U U A U G C U U U G C U G U A U G A C C A G U U G C U G U A G U U G U C U C A A G G G C U G U U G U U C U U G U G G A U C C U G C U G C A A A U U U G A U G A A G A C G A C U C U G A G C C A G U G C U C A A A G G A G U C A A A U U A C A U U A C A C A U A A A C G A A C U U A U G G A U U U G U U U A U G A G A A U C U U C AA U U G G A A C U G U A A C U U U G A A G C A A G G U G A A A U C A A G G A U G C U A C U C C U U C A G A U U U U G U U C G C G C U A C U G C A A C G A U A C C G A U A C A A G C C U C A C U C C C U U U C G G A U G G C U U A U U G U U G G C G U U G C A C U U C U U G C U G U U U U U C A G A G C G C U U C C A A A A U C A U A A C C C U C A A A A A G A G A U G G C A A C U A G C A C U C U C C A A G G G U G U U C A C U U U G U U U G C A A C U U G C U G U U G U U G U U U G U A A C A G U U U A C U C A C A C C U U U U G C U C G U U G C U G C U G G C C U U G A A G C C C C U U U U C U C U A U C U U U A U G C U U U A G U C U A C U U C U U G C A G A G U A U A A A C U U U G U A A G A A U A A U A A U G A G G C U U U G G C U U U G C U G G A A A U G C C G U U C C A A A A 25500 25600 25700 25800 A C C C A U U A C U U U A U G A U G C C A A C U A U U U U C U U U G C U G G C A U A C U A A U U G U U A C G A C U A U U G U A U A C C U U A C A A U A G U G U A A C U U C U U C A A U U G U C A U U A C U U C A G G U G A U G G C A C A A C A A G U C C U A U U U C U G A A C A U G A C U A C C A G A U U G G U G G U U A U A C U G A A A A A U G G G A A U C U G G A G U A A A A G A C U G U G U U G U A U U A C A C A G U U A C U U C A C U U C A G A C U A U U A C C A G C U G U A C U C A A C U C A A U U G A G U A C A G A C A C U G G U G U U G A A C A U G U U A C C U U C U U C A U C U A C A A U A A A A U U G U U G A U G A G C C U G A A G A A C A U G U C C A A 25900 26000 26100 A U U C A C A C A A U C G A C G G U U C A U C C G G A G U U G U U A A U C C A G U A A U G G A A C C A A U U U A U G A U G A A C C G A C G A C G A C U A C U A G C G U G C C U U U G U A A G C A C A A G C U G A U G A G U A C G A A C U U A U G U A C U C A U U C G U U U C G G A A G A G A C A G G U A C G U U A A U A G U U A A U A G C G U A C U U C U U U U U C U U G C U U U C G U G G U A U U C U U G C U A G U U A C A C U A G C C A U C C U U A C U G C G C U U C G A U U G U G U G 26200 26300 Stop codon C G U A C U G C U G C A A U A U U G U U A A C G U G A G U C U U G U A A A A C C U U C U U U U U A C G U U U A C U C U C G U G U U A A A A A U C U G A A U U C U U C U A G A G U U C C U G A U C U U C U G G U C U A A A C G A A C U A A A U A U U A U A U U A G U U U U U C U G U U U G G A A C U U U A A U U U U A G C C A U G G C A G A U U C C A A C G G U A C U A U U A C C G U U G A A G A G C U U A A A A A G C U C C U U G A A C A A U G G A A C C U A G U A A U A G G U U U C C U A U U C C U U A C A U G G A U U U G U C U U C U A C A A U U U G C C U A U G C C A A C A G G A A U A G G U U U U U G U A U A U A A U U A A G U U A A U U U U C C U C U G G C U G U U A U G G C C A G U A A C U U U A G C U U G U U U U G U G C U U G C U G C 26400 26500 26600 26700 Stop codon C G C U U C U A G A A A G U G A A C U C G U A A U C G G A G C U G U G A U C C U U C G U G G A C A U C U U C G U A U U G C U G G A C A C C A U C U A G G A C G U G U U U A C A G A A U A A A U U G G A U C A C C G G U G G A A U U G C U A U C G C A A U G G C U U G U C U U G U A G G C U U G A U G U G G C U C A G C U A C U U C A U U G C U U C U U U C A G A C U G U U U G C G C G U A C G C G U U C C A U G U G G U C A U U C A A U C C A G A A A C U A A C A U U C U U C U C A A C G U G C C A C U C C A U G G C A C U A U U C U G A C C A G A C C U G U G A 26800 26900 27000 C A U C A A G G A C C U G C C U A A A G A A A U C A C U G U U G C U A C A U C A C G A A C G C U U U C U U A U U A C A A A U U G G G A G C U U C G C A G C G U G U A G C A G G U G A C U C A G G U U U U G C U G C A U A C A G U C G C U A C A G G A U U G G C A A C U A U A A A U U A A A C A C A G A C C A U U C C A G U A G C A G U 27100 G A C A A U A U U G C U U U G C U U G U A C A G U A A G U G A C A A C A G A U G U U U C A U C U C G U U G A C U U U C A G G U U A C U A U A G C A G A G A U A U U A C U A A U U A U U A U G A G G A C U U U U A A A G U U U C C A U U U G G A A U C U U G A U U A C A U C A U A A A C C U C A U A A U U A A A A A U U U A U C U A A G U C A C U A A C U G A G A A U A A A U A U U C U C A A U U A G A U G A 27200 27300 A G A G C A A C C A A U G G A G A U U G A U U A A A C G A A C A U G A A A A U U A U U C U U U U C U U G G C A C U G A U A A C A C U C G C U A C U U G U G A G C U U U A U C A C U A C C A A G A G U G U G U U A G A G G U A C A A C A G U A C U U U U A A A A G A A C C U U G C U C U U C U G G A A C A U A C G A G G G C A A U U C A C C A U U U C A U C C U C U A G C U G A U A A C A A A U U U G C A C U G A C U U G C U U U A G C A C U C A A U U U G C U U U U G C U U G U C C U G A C G G C G U A A A A C A C G U C U A U C A G U U A C G U G C C A G A U C A G U U U C A C C U A A A C U G U U C A U C A G A C A A G A G G A A G U U C A A G A A C U U U A C U C U C C A A U U U U U C U U A U U G U U G C G G C A A U A G U G U U U A U A A C A C U U U G C U U C A C A C U C A A A A G A A A G A C A G A A U G A U U G A A C U U U C A U U A A U U G A C U U C U A U U 27400 27500 27600 27700 U G C C U U U A A U U G A A U U G U G C G U G G A U G A G G C U G G U U C U A A A U C A C C C A U U C A G U A C A U C G A U A U C G G U A A U U A U A C A G U U U C C U G U U U A C C U U U U A C A A U U A A U U G C C A G G A A C C U A A A U U G G G U A G U C U U G U A G U G C G U U G U U C G U U C U A U G A A G A C U U U U U A G A G U A U C A U G A C G U U C G U G U U G U U U U A G A U U U C A U C U A A A C G A A C A A A C U A A A A U G U C U G A U A A U G G A C C C C A A A A U C A G C G A A A U G C A C C C C G C A U U A C G U U U G G U G G A C C C U C A G A U U C A A C U G G C A G U A A C C A G A A U G G A G A A C G C A G U G G G G C G C G A U C A A A A C A A C G U C G G C C C C A A G G U U U A C C C A A U A A U A C U G C G U C U U G G U U C 28100 28200 28300 28400 U G C U U U U U A G C C U U U C U G C U A U U C C U U G U U U U A A U U A U G C U U A U U A U C U U U U G G U U C U C A C U U G A A C U G C A A G A U C A U A A U G A A A C U U G U C A C G C C U A A A C G A A C A U G A A A U U U C U U G U U U U C U U A G G A A U C A U C A C A A C U G U A G C U G C A U U U C A C C A A G A A U G U A G U U U A C A G U C A U G U A C U C A A C A U C A A C C A U A U G U A G U U G A U G A C C C G U G U C C U A U U C A C U U C U A U U C U A A A U G G U A U A U U A G A G U A G G A G C U A G A A A A U C A G C A 27800 27900 28000 Stop codon A C C G C U C U C A C U C A A C A U G G C A A G G A A G A C C U U A A A U U C C C U C G A G G A C A A G G C G U U C C A A U U A A C A C C A A U A G C A G U C C A G A U G A C C A A A U U G G C U A C U A C C G A A G A G C U A C C A G A C G A A U U C G U G G U G G U G A C G G U A A A A U G A A A G A U C U C A G U C C A A G A U G G U A U U U C U A C U A C C U A G G A A C U G G G C C A G A A G C U G G A C U U C C C U A U G G U G C U A A C A A A G A C G G C A U C A U A U G G G U U G C A A C U G A G G G A G C C U U G A A U A C A C C A A A A G A U C A C A U U G G C A C C C G C A A U C C U G C U A A C A A U G C U G C A A U C G U G C U A C A A C U U C C U C A A G G A A C A A C A U U G C C A A A A G G C U U C U A C G C A G A A G G G A G C A G A G G C G G C A G U C A A G C C U C U U C U C G U U C C U C A U C A C G U A G U C G C A A C A G U U C A A G A A A U U C A A C U C C A G G C A G C A G U A G G G G A A C U U C U C C U G C U A G A A U G G C U G G C A A U G G C G G U G A U G C U G C U C U U G C U U U G C U G C U G C U U G A C A G A U U G A A C C A G C U U G A G A G C A A A A U G U C U G G U A A A G G C C A A C A A C A A C A A G G C C A A A C U 28500 28600 28700 28800 28900 29000 G C A A A U U G C A C A A U U U G C C C C C A G C G C U U C A G C G U U C U U C G G A A U G U C G C G C A U U G G C A U G G A A G U C A C A C C U U C G G G A A C G U G G U U G A C C U A C A C A G G U G C C A U C A A A U U G G A U G A C A A A G A U C C A A A U U U C A A A G A U C A A G U C A U U U U G C U G A A U A A G C A U A U U G A C G C A U A C A A A A C A U U C C C A C C A A C A G A G C C U A A A A A G G A C A A A A A G A A G A A G G C U G A U G A A A C U C A A G C C U U G U C A C U A A G A A A U C U G C U G C U G A G G C U U C U A A G A A G C C U C G G C A A A A A C G U A C U G C C A C U A A A G C A U A C A A U G U A A C A C A A G C U U U C G G C A G A C G U G G U C C A G A A C A A A C C C A A G G A A A U U U U G G G G A C C A G G A A C U A A U C A G A C A A G G A A C U G A U U A C A A A C A U U G G C C 29100 29200 29300 29400 A C C G C A G A G A C A G A A G A A A C A G C A A A C U G U G A C U C U U C U U C C U G C U G C A G A U U U G G A U G A U U U C U C C A A A C A A U U G C A A C A A U C C A U G A G C A G U G C U G A C U C A A C U C A G G C C U A A A C U C A U G C A G A C C A C A C A A G G C A G A U G G G C U A U A U A A A C G U U U U C G C U U U U C C G U U U A C G A U A U A U A G U C U A C U C U U G U G 29500 29600 Stop codon C A G A A U G A A U U C U C G U A A C U A C A U A G C A C A A G U A G A U G U A G U U A A C U U U A A U C U C A C A U A G C A A U C U U U A A U C A G U G U G U A A C A U U A G G G A G G A C U U G A A A G A G C C A C C A C A U U U U C A C C G A G G C C A C G C G G A G U A C G A U C G A G U G U A C A G U G A A C A A U G C U A G G G A G A G C U G C C U A U A U G G A A G A G C C C U A A U G U G U A A A A U U A A U U U U A G U A G U G C U A U C C C C A U G U G A U U U U A A U A G C U U C U U A G G A G A AHC oV -N L6 3 G A U A A A A G G U A G U A G C U G C G U G C U A U C G C C G A U C C U A A C C C C C G U U U C G U C U U G U A C G A A U C A C U C U U G A A C G A A C U U A A A A U U G C A U C A U A C G U C A C G G U A G G U U U C G U C U U G C U G U G C G U A C G U U G C A C A C C A A U U A U A G U G G A G C U U U U U G G U U A A G U A C U U C C C C C U U G C G A G C A A C A G G U G U C G U C C U G U U U G U U A G C C C U G C G C G G U U U C G U C C G U G U A G U G A U G G A G G G U G U G C C U G A C C C A C C U A A G C U U A A A A G U A U G G U G G U U A C C A C U U U G A A G U G G U G C G A U C C U U U U G C U A A U C C C A A C G U C A C U G G U U G G G A U A U U1SL1 SL2 SL3 SL4 SL5 SL6 SL7 G A U U U A A G U G A A U A G C U U G G C U A U C U C A C U U C C C C U C G U U C U C U U G C A G A A C U U U G A U U U U A A C G A A C U U A A A U A A A A G C C C U G U U G U U U A G C G U A U C G U U G C A C U U G U C U G G U G G G A U U G U G G C A U U A A U U U G C C U G C U C A U C U A G G C A G U G G A C A U A U G C U C A A C A C U G G G U A U A A U U C U A A U U G A A U A C U A U U U U U C A G U U A G A G C G U C G U G U C U C U U G U A C G U C U C G G U C A C A A U A C A C G G U U U C G U C C G G U G C G U G G C A A U U C G G G G C A C A U C A U G U C U U U C G U G G C U G G U G U G A C C G C G C A A G G U G C G C G C G G U A C G U A U C G A G C A G C G C U C A A C U C U G A A A A A C A U C A A G A C C A U G U G U C U C U A A C U G U G C C A C U C U G U G G U U C A G G A A A C C U G G U U G A A A A A C U U U C A C C A U G G U U C A U G G A U G G C G A A A A U G C C U A U G A A G U G G U G A A G G CA U U A A A G G U U U A U A C C U U C C C A G G U A A C A A A C C A A C C A A C U U U C G A U C U C U U G U A G A U C U G U U C U C U A A A C G A A C U U U A A A A U C U G U G U G G C U G U C A C U C G G C U G C A U G C U U A G U G C A C U C A C G C A G U A U A A U U A A U A A C U A A U U A C U G U C G U U G A C A G G A C A C G A G U A A C U C G U C U A U C U U C U G C A G G C U G C U U A C G G U U U C G U C C G U G U U G C A G C C G A U C A U C A G C A C A U C U A G G U U U C G U C C G G G U G U G A C C G A A A G G U A A G A U G G A G A G C C U U G U C C C U G G U U U C A A C G A G A A A A C A C A C G U C C A A C U C A G U U U G C C U G U U U U A C A G G U U C G C G A C G U G C U C G U A C G U G G C U U U G G A G A C U C C G U G G A G G A G G U C U U A U C A G A G G C A C G UU C C C A G G U A A C A A A C C A A C C A A C U U U C G A U C U C U U G U A G A U C U G U U C U C U A A A C A G G A C U C U U U A A A G A U U G U A G U AG U G U G G C U G U C A C U C G G C U G C A U G C U U A G U G C A C U C A C G C A G U A U A A U U A A U A A C

Zika virus produces noncoding RNAs using a multipseudoknot structure that confounds a cellular exonuclease

An in silico map of the SARS-CoV-2 RNA Structurome

Innate immune evasion strategies of DNA and RNA viruses

Analyses of mRNA structure dynamics identify embryonic gene regulatory programs

Genome-Wide Analysis of RNA Secondary Structure

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Hierarchy and dynamics of RNA folding

Overlapping local and long-range RNA-RNA interactions modulate dengue virus genome cyclization and replication

Pervasive tertiary structure in the dengue virus RNA genome

An interactive web-based dashboard to track COVID-19 in real time

Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly

Biochemical aspects of coronavirus replication and virus-host interaction

Dengue virus genomic variation associated with mosquito adaptation defines the pattern of viral non-coding RNAs and fitness in human cells

Structural and mechanistic insights into hepatitis C viral translation initiation

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

RNA polymerase II subunits link transcription and mRNA decay to translation

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Rfam 13.0: shifting to a genome-centric resource for non-coding RNA families

Viral IRES RNA structures and ribosome interactions

The Architecture of SARS-CoV-2 Transcriptome

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Structural lability in stem-loop 1 drives a 5' UTR-3' UTR interaction in coronavirus replication

icSHAPE-pipe: A comprehensive toolkit for icSHAPE data analysis and evaluation

Integrative Analysis of Zika Virus Genome RNA Structure Reveals Critical Determinants of Viral Infectivity

Diverse roles of host RNA binding proteins in RNA virus replication

Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules

Insights into RNA structure and function from genome-wide studies

Pervasive Regulatory Functions of mRNA Structure Revealed by High-Resolution SHAPE Probing

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Functional long-range RNA-RNA interactions in positivestrand RNA viruses

Antiviral innate immunity and stress granule responses

An RNA-centric dissection of host complexes controlling flavivirus infection

Coronavirus as a possible cause of severe acute respiratory syndrome

RNA Regulations and Functions Decoded by

Transcriptome-wide RNA Structure Probing

The Coding Region of the HCV Genome Contains a Network of Regulatory RNA Structures

De novo 3D models of SARS-CoV-2 RNA elements and small-molecule-binding RNAs to guide drug discovery

Ro60-associated RNA takes its toll on disease pathogenesis

c-di-AMP binds the ydaO riboswitch in two pseudo-symmetryrelated pockets

RNAstructure: software for RNA secondary structure prediction and analysis

The structure of a rigorously conserved RNA element within the SARS virus genome

Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus

Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation

The polypyrimidine tract-binding protein affects coronavirus RNA accumulation levels and relocalizes viral RNAs to novel cytoplasmic domains different from replication-transcription sites

The polypyrimidine tract-binding protein affects coronavirus RNA accumulation levels and relocalizes viral RNAs to novel cytoplasmic domains different from replication-transcription sites

Structural imprints in vivo decode RNA regulatory mechanisms

RNA structure maps across mammalian cellular compartments

Predicting dynamic cellular protein-RNA interactions using deep learning and in vivo RNA structure

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Understanding the transcriptome through RNA structure

Architecture and secondary structure of an entire HIV-1 RNA genome

A new coronavirus associated with human respiratory disease in China

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

The nucleocapsid protein of SARS-associated coronavirus inhibits B23 phosphorylation

Promoter sequences direct cytoplasmic localization and translation of mRNAs during starvation in yeast

We thank members of the Zhang lab for discussion. We thank Professor Jianbin Wang for the help of the project. This work is supported by the National Natural Science Foundation 

The authors declare no competing interests.